Dr. Trevejo paper in Nature Biotechnology highlights critical considerations in the race to develop COVID-19 vaccines and antibody countermeasures.

In this important race to develop protections and treatments, key facets of the biology of SARS-CoV-2 are critical for consideration. A recent Nature Biotechnology publication written in collaboration with HelixNano and Dr. George Church of the Harvard, Wyss Institute discusses these biological paradigms of SARS-CoV-2. We discuss some of the important considerations and measures to be taken for the creation and development of vaccines as well as monoclonal antibodies.